<p>Vevizye is a medicine for adults with moderate to severe dry eye disease (also known as keratoconjunctivitis sicca) which has not improved despite treatment with tear substitutes.</p><p>Vevizye contains the active substance ciclosporin. </p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Treatment of moderate to severe dry eye disease (keratoconjunctivitis sicca)<em> </em>in adult patients, which has not improved despite treatment with tear substitutes.</p></div>
Therapeutic Area (MeSH)
ATC Code
S01XA18
ATC Item
N/A
Pharmacotherapeutic Group
Ophthalmologicals
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| ciclosporin | N/A | ciclosporin |
EMA Name
Vevizye
Medicine Name
Vevizye
Aliases
N/ANo risk management plan link.
